prodchem
Aug 12, 2026
Evonik's cash-generation performance provides an important benchmark for assessing financial discipline across the European chemical industry.
The company achieved a 37% cash conversion rate in 2025, reaching the upper end of its previous 30%–40% target range. For 2026, Evonik continues to target a cash conversion rate of around 40%, making the gap between recent performance and the new ambition relatively narrow.
That target matters because cash conversion measures how effectively operating earnings translate into free cash flow. For a capital-intensive chemical producer, stronger conversion can support debt reduction, investment and shareholder distributions without relying as heavily on external financing.
Chemical companies can report healthy EBITDA while generating substantially less cash.
Working-capital requirements, capital expenditure, restructuring costs and other cash items can create a meaningful gap between accounting earnings and actual free cash flow.
Cash conversion therefore provides investors with another way to evaluate the quality of earnings.
A company that consistently converts a high proportion of earnings into cash has greater financial flexibility.
Evonik generated approximately €695 million of free cash flow in 2025, compared with €873 million in 2024.
Despite the lower absolute free cash flow, the company's cash conversion rate reached 37%, placing it at the top of its previous 30%–40% target range.
This creates a relatively strong starting position for the company's 2026 ambition.
Moving from 37% actual conversion to approximately 40% represents only a three-percentage-point improvement.
That may appear modest.
However, achieving a consistently higher conversion rate can become increasingly difficult when economic conditions remain challenging.
The real test will therefore be whether Evonik can sustain cash generation while simultaneously funding operations, restructuring and strategic investments.
Evonik initially expected 2026 adjusted EBITDA of between €1.7 billion and €2.0 billion.
By June 2026, the company had raised that outlook to €2.0 billion–€2.2 billion, following a stronger-than-expected second quarter.
This creates an interesting backdrop for the cash-conversion target.
Higher earnings provide greater potential cash generation, but the company must still convert those earnings efficiently.
Evonik expected second-quarter adjusted EBITDA of €600 million–€650 million, representing a significant improvement over the prior-year quarter.
The company attributed the improvement to higher sales volumes, higher prices and ongoing cost reductions.
The stronger earnings environment could make the 40% cash-conversion target more achievable, assuming working capital and capital spending remain under control.
Cost reduction is an important part of Evonik's financial strategy.
Its efficiency program, Evonik Tailor Made, is intended to simplify structures and reduce costs, including through workforce reductions.
Lower recurring costs can support both EBITDA and free cash flow.
However, restructuring itself can involve short-term cash expenses, meaning the timing of savings and cash costs remains important.
Cash conversion can fluctuate significantly because of working-capital movements.
Inventory levels, receivables and payables can all affect free cash flow even when underlying operating profitability remains relatively stable.
For Evonik, investors therefore need to distinguish between structural improvements in cash generation and temporary working-capital benefits.
Chemical manufacturing requires continued investment in:
Production facilities
Maintenance
Safety
Technology
Capacity upgrades
Sustainability projects
Aggressive reductions in capital expenditure could temporarily improve cash conversion but may not necessarily strengthen the business over the long term.
The better outcome is higher conversion while maintaining disciplined strategic investment.
European chemical producers continue to operate in a challenging environment involving:
High energy costs
Weak industrial demand
Global competition
Currency volatility
Regulatory pressure
Strong cash generation gives companies greater flexibility when these conditions persist.
Evonik's 40% ambition should therefore be viewed as part of a broader financial-discipline strategy.
Starting in 2026, Evonik introduced a new dividend policy under which between 40% and 60% of adjusted net income is intended to be distributed to shareholders.
This makes cash generation particularly important.
The company needs to balance shareholder distributions with:
Debt reduction
Capital investment
Strategic projects
Restructuring
Liquidity
Strong cash conversion can make that balance easier to manage.
Evonik is also targeting a medium-term 11% return on capital employed, compared with 6.1% achieved in 2025.
This means cash conversion is only one part of the company's broader capital-efficiency agenda.
The company is simultaneously trying to improve:
cash generation + capital returns + earnings quality.
High cash conversion does not automatically mean high returns on capital.
A company can generate substantial cash while still earning inadequate returns on a large asset base.
That is why Evonik's 40% cash-conversion target should be assessed alongside its 11% ROCE ambition.
Together, the metrics provide a more complete picture of capital discipline.
Evonik has been reshaping its portfolio toward businesses where it believes it can achieve stronger competitive positions and returns.
Portfolio simplification can potentially:
Reduce capital intensity
Improve management focus
Release cash
Lower complexity
Strengthen returns
This makes portfolio strategy another factor investors should consider when evaluating future cash conversion.
Evonik operates across several specialty and advanced-technology businesses.
These businesses can have different:
Margin structures
Working-capital requirements
Capital-intensity levels
Pricing dynamics
As portfolio composition changes, the company's overall cash-conversion profile can also change.
Evonik's improved earnings outlook is encouraging, but the company still expects uncertainty.
Its June outlook noted that some favorable supply-chain conditions could weaken later in the year as global marine shipping normalizes.
That creates a potential challenge for maintaining strong cash generation.
This distinction is important.
Higher EBITDA can improve the numerator in a cash-conversion calculation, but cash generation can still be affected by:
Inventory investment
Customer receivables
Capital expenditure
Restructuring payments
Tax payments
Other cash items
Therefore, quarterly EBITDA growth should not be treated as a direct proxy for free cash flow.
Very High
The target represents a clear capital-discipline benchmark for 2026.
Very High
Reaching 37% already puts Evonik close to its 2026 ambition.
High
The cash-generation base provides an important reference point for measuring future progress.
High
The upgraded €2.0 billion–€2.2 billion EBITDA outlook increases the potential cash-generation opportunity.
High
Improving returns on capital complements the cash-conversion strategy.
High
Efficiency initiatives can support recurring cash generation if savings outweigh restructuring costs.
The most important indicators include:
Cash conversion rate
Free cash flow
Adjusted EBITDA
Working-capital movements
Capital expenditure
Net debt
ROCE
Restructuring costs
Dividend payments
Cost savings
Portfolio changes
Tracking these metrics together will provide a clearer picture of whether Evonik's capital-discipline strategy is working.
For customers sourcing specialty chemical materials, stronger cash generation can also have indirect implications.
A financially disciplined producer may have greater capacity to:
Maintain production assets
Invest in manufacturing reliability
Support innovation
Fund sustainability projects
Maintain supply-chain resilience
Financial strength can therefore become relevant to supplier-risk assessments.
Featured Product
Found this useful?
Continue Reading
Mosaic's Q2 2026 segment performance shows a clear divergence across its fertilizer businesses. Potash remained steady at $278 million in adjusted EBITDA while Phosphate and Fertilizantes posted losses, creating important sourcing signals for fertilizer buyers.
Albemarle's $1.3 billion debt tender and redemption in Q1 2026 drove net debt/EBITDA down to 0.5x. The turnaround changes how chemical buyers, suppliers and investors can assess the company's financial resilience.
The UK's new S-PVC anti-dumping investigation involving China, Mexico and South Korea adds another important case to the country's growing 2026 trade-defense pipeline, with potential implications for polymer pricing, sourcing and downstream manufacturing.
